{
    "2018-08-14": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Three expansions, 923 jobs: Durham County approves incentives packages",
                "features": {
                    "keywords": [
                        "expansions",
                        "jobs",
                        "incentives"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "real estate",
                        "employment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-02-28",
                "original_text": "Array BioPharma Inc. (ARRY) Q4 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "earnings",
                        "conference call",
                        "Q4"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Regeneron's 12-Week Eylea Dose Gets CRL From FDA for Wet AMD",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Eylea",
                        "CRL",
                        "FDA",
                        "Wet AMD"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Regeneron's 12-Week Eylea Dose Gets CRL From FDA for Wet AMD",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Eylea",
                        "CRL",
                        "FDA",
                        "Wet AMD"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Pfizer Expected to Report Robust EPS Rise in Fiscal 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "EPS",
                        "rise",
                        "fiscal 2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "What Drove GlaxoSmithKline’s Consumer Healthcare Segment in Q2",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "consumer healthcare",
                        "Q2"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-25",
                "original_text": "The Swiss Stock Market Clung To A Small Increase",
                "features": {
                    "keywords": [
                        "Swiss stock market",
                        "small increase"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "stock market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Pfizer Is Expected to Report Modest Revenue Rise in Fiscal 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "revenue rise",
                        "fiscal 2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "GlaxoSmithKline’s Pharmaceuticals Segment in Q2 2018",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "pharmaceuticals",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Novartis recruits new compliance head from Siemens after ethics stumbles",
                "features": {
                    "keywords": [
                        "Novartis",
                        "compliance head",
                        "Siemens",
                        "ethics"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}